CSHL Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1987-2021

FUNDING AMOUNT

78504589 USD

ABSTRACT

CSHL Cancer Center ? Overall Project Summary/Abstract The Cold Spring Harbor Laboratory (CSHL) Cancer Center is a premier cancer research center that uses innovative and collaborative approaches to address some of the most pressing challenges facing cancer biologists and cancer patients today. In particular, research in CSHL Cancer Center is focused on two primary problems: improving cancer diagnostics and increasing therapeutic effectiveness. Researchers in the CSHL Cancer Center are employing cutting edge genetic and genomic approaches to molecularly characterize cancer. The goals of this research are to both develop new diagnostic tools and to also define cancer subtypes so that clinicians will be able to select the most effective therapeutic approaches. CSHL Cancer Center researchers are at the forefront of developing and applying these genomic approaches; discoveries like single cell sequencing have the power to revolutionize diagnostics and are already demonstrating tremendous potential in the clinic. The CSHL Cancer Center is building upon its outstanding foundation in basic discovery science to identify and develop new therapeutic targets for multiple tumor types. More than ten years ago, the Cancer Center formalized this strategy with the creation of a ?cancer discovery pipeline.? The plan integrated basic cancer biology, human cancer genetics, high-throughput screening technology, and innovative animal models in an effort to improve existing treatments for cancer. This pipeline has been tremendously successful. Cancer Center researchers have discovered new cancer genes, identified potential therapeutic targets, and explored new drug resistance mechanisms. As this basic research continues, the Cancer Center is aiming to extend the pipeline even further into translational research. Over the next five years, as part of a Cancer Therapeutics Initiative, the Cancer Center will bring its basic research discoveries to preclinical and clinical settings. Funding from the National Cancer Institute provides the CSHL Cancer Center with the organizational and financial support needed to make a significant impact on cancer diagnosis and treatment. The three research programs (Gene Regulation & Cell Proliferation; Signal Transduction; Cancer Genetics) provide opportunities for members to come together, maximizing collaboration and communication. The nine Shared Resources provide access to technologies, services, and expertise to enhance productivity and promote multidisciplinary interactions. Essential Developmental Funds enable the Center to remain at the forefront of cancer research. Together, these elements of the CSHL Cancer Center create an environment that supports the level of scientific discovery required to make real progress in improving cancer diagnosis and treatment. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9518620

Related SciGraph Publications

  • 2018-12. Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development in NATURE COMMUNICATIONS
  • 2018-12. DNA sequence-level analyses reveal potential phenotypic modifiers in a large family with psychiatric disorders in MOLECULAR PSYCHIATRY
  • 2018-10-31. Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens in PANCREATIC CANCER
  • 2018-10-31. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma in PANCREATIC CANCER
  • 2018-03-20. A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma in BRITISH JOURNAL OF CANCER
  • 2018-03. Dynamic evolution of regulatory element ensembles in primate CD4+ T cells in NATURE ECOLOGY & EVOLUTION
  • 2018-02. Transposon-derived small RNAs triggered by miR845 mediate genome dosage response in Arabidopsis in NATURE GENETICS
  • 2018-02. Asparagine bioavailability governs metastasis in a model of breast cancer in NATURE
  • 2017-12. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2017-12. Hybrid assembly with long and short reads improves discovery of gene family expansions in BMC GENOMICS
  • 2017-12. Whole genome sequencing of one complex pedigree illustrates challenges with genomic medicine in BMC MEDICAL GENOMICS
  • 2017-08. Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2017-06. Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma in NATURE GENETICS
  • 2017-04. Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data in NATURE GENETICS
  • 2017-03. Structural basis of Mcm2-7 replicative helicase loading by ORC-Cdc6 and Cdt1 in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2017-03. Untangling the genetics from the epigenetics in pancreatic cancer metastasis in NATURE GENETICS
  • 2017-02-22. Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization in NATURE COMMUNICATIONS
  • 2017-02-06. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples in NATURE MEDICINE
  • 2017-02. Cancer: Double trouble for tumours in NATURE
  • 2017-01. Is a super-enhancer greater than the sum of its parts? in NATURE GENETICS
  • 2016-12. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation in BMC BIOLOGY
  • 2016-12. Gene-specific patterns of expression variation across organs and species in GENOME BIOLOGY
  • 2016-12. Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein in BMC MOLECULAR BIOLOGY
  • 2016-11-17. Indel variant analysis of short-read sequencing data with Scalpel in NATURE PROTOCOLS
  • 2016-09. Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition in NATURE CHEMICAL BIOLOGY
  • 2016-09. Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas in SCIENTIFIC REPORTS
  • 2016-08. Building up the tension between the epithelial and stromal compartment in pancreatic ductal adenocarcinoma in CELL DEATH & DIFFERENTIATION
  • 2016-06. Coming of age: ten years of next-generation sequencing technologies in NATURE REVIEWS GENETICS
  • 2016-05. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis in NATURE CELL BIOLOGY
  • 2016-04-21. Pancreatic cancer in NATURE REVIEWS DISEASE PRIMERS
  • 2016-04. Inducing stable reversion to achieve cancer control in NATURE REVIEWS CANCER
  • 2016-03. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms in NATURE
  • 2016-02. Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay in NATURE BIOTECHNOLOGY
  • 2016-01. Substantial contribution of extrinsic risk factors to cancer development in NATURE
  • 2016. Time to Shine the Spotlight on the Protein Tyrosine Phosphatase Family of Signal Transducing Enzymes in PROTEIN TYROSINE PHOSPHATASES IN CANCER
  • 2016. Optimizing RNA-Seq Mapping with STAR in DATA MINING TECHNIQUES FOR THE LIFE SCIENCES
  • 2015-12. The spliceosome, a potential Achilles heel of MYC-driven tumors in GENOME MEDICINE
  • 2015-12. Enhanced transcriptome maps from multiple mouse tissues reveal evolutionary constraint in gene expression in NATURE COMMUNICATIONS
  • 2015-12. Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2 in BMC GENOMICS
  • 2015-12. SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes in NATURE COMMUNICATIONS
  • 2015-12. ADAM8 as a drug target in pancreatic cancer in NATURE COMMUNICATIONS
  • 2015-12. Differential connectivity of splicing activators and repressors to the human spliceosome in GENOME BIOLOGY
  • 2015-11. Interactive analysis and assessment of single-cell copy-number variations in NATURE METHODS
  • 2015-09. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition in NATURE
  • 2015-06. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains in NATURE BIOTECHNOLOGY
  • 2015-04. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis in NATURE
  • 2015-04. A common functional consequence of tumor-derived mutations within c-MYC in ONCOGENE
  • 2015-02. Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion in NATURE NEUROSCIENCE
  • 2014-12. Chd5 orchestrates chromatin remodelling during sperm development in NATURE COMMUNICATIONS
  • 2014-12. Reducing INDEL calling errors in whole genome and exome sequencing data in GENOME MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "78504589"
        }, 
        "description": "CSHL Cancer Center ? Overall Project Summary/Abstract The Cold Spring Harbor Laboratory (CSHL) Cancer Center is a premier cancer research center that uses innovative and collaborative approaches to address some of the most pressing challenges facing cancer biologists and cancer patients today. In particular, research in CSHL Cancer Center is focused on two primary problems: improving cancer diagnostics and increasing therapeutic effectiveness. Researchers in the CSHL Cancer Center are employing cutting edge genetic and genomic approaches to molecularly characterize cancer. The goals of this research are to both develop new diagnostic tools and to also define cancer subtypes so that clinicians will be able to select the most effective therapeutic approaches. CSHL Cancer Center researchers are at the forefront of developing and applying these genomic approaches; discoveries like single cell sequencing have the power to revolutionize diagnostics and are already demonstrating tremendous potential in the clinic. The CSHL Cancer Center is building upon its outstanding foundation in basic discovery science to identify and develop new therapeutic targets for multiple tumor types. More than ten years ago, the Cancer Center formalized this strategy with the creation of a ?cancer discovery pipeline.? The plan integrated basic cancer biology, human cancer genetics, high-throughput screening technology, and innovative animal models in an effort to improve existing treatments for cancer. This pipeline has been tremendously successful. Cancer Center researchers have discovered new cancer genes, identified potential therapeutic targets, and explored new drug resistance mechanisms. As this basic research continues, the Cancer Center is aiming to extend the pipeline even further into translational research. Over the next five years, as part of a Cancer Therapeutics Initiative, the Cancer Center will bring its basic research discoveries to preclinical and clinical settings. Funding from the National Cancer Institute provides the CSHL Cancer Center with the organizational and financial support needed to make a significant impact on cancer diagnosis and treatment. The three research programs (Gene Regulation & Cell Proliferation; Signal Transduction; Cancer Genetics) provide opportunities for members to come together, maximizing collaboration and communication. The nine Shared Resources provide access to technologies, services, and expertise to enhance productivity and promote multidisciplinary interactions. Essential Developmental Funds enable the Center to remain at the forefront of cancer research. Together, these elements of the CSHL Cancer Center create an environment that supports the level of scientific discovery required to make real progress in improving cancer diagnosis and treatment.", 
        "endDate": "2021-07-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438853", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438853"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA045508"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "translational research", 
          "Shared Resources", 
          "single cell sequencing", 
          "outstanding foundation", 
          "levels", 
          "Cold Spring Harbor Laboratory", 
          "financial support", 
          "National Cancer Institute", 
          "diagnostics", 
          "clinic", 
          "Cancer Therapeutics Initiative", 
          "abstract", 
          "Overall Project Summary", 
          "CSHL Cancer Center Support Grant", 
          "elements", 
          "Essential Developmental Funds", 
          "effective therapeutic approach", 
          "years", 
          "cancer biologists", 
          "genomic approaches", 
          "pipeline", 
          "communication", 
          "research", 
          "edge", 
          "CSHL Cancer Center researchers", 
          "pressing challenges", 
          "strategies", 
          "collaborative approach", 
          "creation", 
          "members", 
          "basic research", 
          "clinical setting", 
          "center", 
          "cancer diagnosis", 
          "primary problem", 
          "therapeutic effectiveness", 
          "discovery", 
          "multidisciplinary interactions", 
          "basic research discoveries", 
          "innovative animal model", 
          "access", 
          "cancer patients today", 
          "expertise", 
          "new drug resistance mechanisms", 
          "productivity", 
          "cancer discovery pipeline", 
          "services", 
          "potential therapeutic target", 
          "multiple tumor types", 
          "forefront", 
          "cancer", 
          "opportunity", 
          "efforts", 
          "Cancer Center researchers", 
          "part", 
          "plan", 
          "researchers", 
          "cancer research", 
          "power", 
          "CSHL Cancer Center", 
          "basic discovery science", 
          "cancer subtypes", 
          "scientific discovery", 
          "Cancer Genetics", 
          "cancer diagnostics", 
          "treatment", 
          "human cancer genetics", 
          "significant impact", 
          "new diagnostic tools", 
          "Gene Regulation & Cell Proliferation", 
          "collaboration", 
          "technology", 
          "premier cancer research center", 
          "signal transduction", 
          "new cancer genes", 
          "environment", 
          "new therapeutic targets", 
          "clinicians", 
          "cancer center", 
          "real progress", 
          "basic cancer biology", 
          "tremendous potential", 
          "research program", 
          "goal"
        ], 
        "name": "CSHL Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.225279.9", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.225279.9", 
              "name": "COLD SPRING HARBOR LABORATORY", 
              "type": "Organization"
            }, 
            "familyName": "TUVESON", 
            "givenName": "DAVID A", 
            "id": "sg:person.01344557251.86", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01344557251.86", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438853"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1987-08-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9518620"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438853'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438853'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438853'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438853'


     

    This table displays all metadata directly associated to this object as RDF triples.

    131 TRIPLES      19 PREDICATES      106 URIs      97 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438853 schema:about anzsrc-for:2206
    2 anzsrc-for:2211
    3 schema:amount N526be26331c042cfb7c753c92f223d29
    4 schema:description CSHL Cancer Center ? Overall Project Summary/Abstract The Cold Spring Harbor Laboratory (CSHL) Cancer Center is a premier cancer research center that uses innovative and collaborative approaches to address some of the most pressing challenges facing cancer biologists and cancer patients today. In particular, research in CSHL Cancer Center is focused on two primary problems: improving cancer diagnostics and increasing therapeutic effectiveness. Researchers in the CSHL Cancer Center are employing cutting edge genetic and genomic approaches to molecularly characterize cancer. The goals of this research are to both develop new diagnostic tools and to also define cancer subtypes so that clinicians will be able to select the most effective therapeutic approaches. CSHL Cancer Center researchers are at the forefront of developing and applying these genomic approaches; discoveries like single cell sequencing have the power to revolutionize diagnostics and are already demonstrating tremendous potential in the clinic. The CSHL Cancer Center is building upon its outstanding foundation in basic discovery science to identify and develop new therapeutic targets for multiple tumor types. More than ten years ago, the Cancer Center formalized this strategy with the creation of a ?cancer discovery pipeline.? The plan integrated basic cancer biology, human cancer genetics, high-throughput screening technology, and innovative animal models in an effort to improve existing treatments for cancer. This pipeline has been tremendously successful. Cancer Center researchers have discovered new cancer genes, identified potential therapeutic targets, and explored new drug resistance mechanisms. As this basic research continues, the Cancer Center is aiming to extend the pipeline even further into translational research. Over the next five years, as part of a Cancer Therapeutics Initiative, the Cancer Center will bring its basic research discoveries to preclinical and clinical settings. Funding from the National Cancer Institute provides the CSHL Cancer Center with the organizational and financial support needed to make a significant impact on cancer diagnosis and treatment. The three research programs (Gene Regulation & Cell Proliferation; Signal Transduction; Cancer Genetics) provide opportunities for members to come together, maximizing collaboration and communication. The nine Shared Resources provide access to technologies, services, and expertise to enhance productivity and promote multidisciplinary interactions. Essential Developmental Funds enable the Center to remain at the forefront of cancer research. Together, these elements of the CSHL Cancer Center create an environment that supports the level of scientific discovery required to make real progress in improving cancer diagnosis and treatment.
    5 schema:endDate 2021-07-31T00:00:00Z
    6 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    7 schema:identifier Nae6c90a867994708a33b0b4c4bffc292
    8 Ncf60e0310e8d494596b38013aa5e0866
    9 schema:inLanguage en
    10 schema:keywords CSHL Cancer Center
    11 CSHL Cancer Center Support Grant
    12 CSHL Cancer Center researchers
    13 Cancer Center researchers
    14 Cancer Genetics
    15 Cancer Therapeutics Initiative
    16 Cold Spring Harbor Laboratory
    17 Essential Developmental Funds
    18 Gene Regulation & Cell Proliferation
    19 National Cancer Institute
    20 Overall Project Summary
    21 Shared Resources
    22 abstract
    23 access
    24 basic cancer biology
    25 basic discovery science
    26 basic research
    27 basic research discoveries
    28 cancer
    29 cancer biologists
    30 cancer center
    31 cancer diagnosis
    32 cancer diagnostics
    33 cancer discovery pipeline
    34 cancer patients today
    35 cancer research
    36 cancer subtypes
    37 center
    38 clinic
    39 clinical setting
    40 clinicians
    41 collaboration
    42 collaborative approach
    43 communication
    44 creation
    45 diagnostics
    46 discovery
    47 edge
    48 effective therapeutic approach
    49 efforts
    50 elements
    51 environment
    52 expertise
    53 financial support
    54 forefront
    55 genomic approaches
    56 goal
    57 human cancer genetics
    58 innovative animal model
    59 levels
    60 members
    61 multidisciplinary interactions
    62 multiple tumor types
    63 new cancer genes
    64 new diagnostic tools
    65 new drug resistance mechanisms
    66 new therapeutic targets
    67 opportunity
    68 outstanding foundation
    69 part
    70 pipeline
    71 plan
    72 potential therapeutic target
    73 power
    74 premier cancer research center
    75 pressing challenges
    76 primary problem
    77 productivity
    78 real progress
    79 research
    80 research program
    81 researchers
    82 scientific discovery
    83 services
    84 signal transduction
    85 significant impact
    86 single cell sequencing
    87 strategies
    88 technology
    89 therapeutic effectiveness
    90 translational research
    91 treatment
    92 tremendous potential
    93 years
    94 schema:name CSHL Cancer Center Support Grant
    95 schema:recipient N19327a71d06d4223b8d33461581cfaa7
    96 sg:person.01344557251.86
    97 https://www.grid.ac/institutes/grid.225279.9
    98 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438853
    99 schema:sdDatePublished 2019-03-07T12:11
    100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    101 schema:sdPublisher N2ed5a460972344a6bf6767d04f0e505c
    102 schema:startDate 1987-08-01T00:00:00Z
    103 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9518620
    104 sgo:license sg:explorer/license/
    105 sgo:sdDataset grants
    106 rdf:type schema:MonetaryGrant
    107 N19327a71d06d4223b8d33461581cfaa7 schema:member sg:person.01344557251.86
    108 schema:roleName PI
    109 rdf:type schema:Role
    110 N2ed5a460972344a6bf6767d04f0e505c schema:name Springer Nature - SN SciGraph project
    111 rdf:type schema:Organization
    112 N526be26331c042cfb7c753c92f223d29 schema:currency USD
    113 schema:value 78504589
    114 rdf:type schema:MonetaryAmount
    115 Nae6c90a867994708a33b0b4c4bffc292 schema:name nih_id
    116 schema:value P30CA045508
    117 rdf:type schema:PropertyValue
    118 Ncf60e0310e8d494596b38013aa5e0866 schema:name dimensions_id
    119 schema:value 2438853
    120 rdf:type schema:PropertyValue
    121 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
    122 rdf:type schema:DefinedTerm
    123 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    124 rdf:type schema:DefinedTerm
    125 sg:person.01344557251.86 schema:affiliation https://www.grid.ac/institutes/grid.225279.9
    126 schema:familyName TUVESON
    127 schema:givenName DAVID A
    128 rdf:type schema:Person
    129 https://www.grid.ac/institutes/grid.225279.9 schema:name COLD SPRING HARBOR LABORATORY
    130 rdf:type schema:Organization
    131 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...